Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 6c, Offers Guidance

Cellebrite DI Ltd. (NASDAQ: CLBT) reported Q2 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $95.7 million versus the consensus estimate of $92.19 million.

GUIDANCE:

Cellebrite DI Ltd. sees Q3 2024 revenue of $100-104 million, versus the consensus of $95 million.

Cellebrite DI Ltd. sees FY2024 revenue of $390-398 million, versus the consensus of $378 million.

For earnings history and earnings-related data on Cellebrite DI Ltd. (CLBT) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• HSBC Starts IHH Healthcare (IHH:MK) (IHHHF) at Buy
• Discovery Energy Metals plans private placement of up to $1.25M